The three Sopharma AD factories - the one in Kazanlak, the Tablet production and Ampoule production in Sofia - have Nivalin in common, one of the strongest Sopharma products. Nivalin is sold in more than 10 countries outside Bulgaria, making it one of the most famous Sopharma products. It increases the intensity of the reflex centers of the spinal cord, medulla oblongata and cerebral cortex, thus influences all links of the reflex arc.
Sofia, Bulgaria, March 20, 2024 – According to the requirements of art. 100t of LPOS, “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies that for February 2024 the Company recorded an decrease in sales of 29% compared to the same month of the previous year, incl. 9% decrease in domestic sales and 43% decrease in export sales.
From the beginning of 2024, the Company recorded a decrease in sales of 3%, incl. 2% growth in domestic sales and 7% decrease in export sales.
